Axcella Health Inc (AXLA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
William R. Hinshaw
Employees:
60
840 MEMORIAL DRIVE, THIRD FLOOR, CAMBRIDGE, MA 02139
617-868-0949

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction of risk of overt hepatic encephalopathy recurrence.

Data derived from most recent annual or quarterly report
Market Cap 25.715 Million Shares Outstanding73.683 Million Avg 30-day Volume 42.743 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.08
Price to Revenue0.0 Debt to Equity0.0 EBITDA-62.492 Million
Price to Book Value48.6398 Operating Margin0.0 Enterprise Value22.821 Million
Current Ratio1.071 EPS Growth0.386 Quick Ratio1.054
1 Yr BETA 0.4279 52-week High/Low 2.79 / 0.16 Profit Margin0.0
Operating Cash Flow Growth-1.5684 Altman Z-Score-60.727 Free Cash Flow to Firm -40.385 Million
Earnings Report2023-08-11
View SEC Filings from AXLA instead.

View recent insider trading info

Axcella Health Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AXLA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AXLA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-03 by Koziel Margaret
  • 4: filed on 2023-02-24 by Koziel Margaret
  • 4: filed on 2023-02-24 by HINSHAW WILLIAM
  • 4: filed on 2023-02-24 by FEHLNER PAUL
  • 4: filed on 2023-02-13 by FEHLNER PAUL
  • 4: filed on 2022-11-18 by NISSEN TORBEN STRAIGHT
  • 4: filed on 2022-11-18 by ROSIELLO ROBERT L.
  • 4: filed on 2022-10-19 by HINSHAW WILLIAM
  • 4: filed on 2022-10-17 by AFEYAN NOUBAR
  • 3: filed on 2022-10-17 by FLAGSHIP PIONEERING INC.

    • Events (8k)

  • 8-K: filed on 2023-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-07:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-17:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-04:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-12-15:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-29:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KOZIEL MARGARET CHIEF MEDICAL OFFICER

    • Officer
    		 24,883 2023-03-01 3

    HINSHAW WILLIAM PRESIDENT & CEO

    • Officer
    • Director
    		 0 2023-02-17 2

    FEHLNER PAUL SVP & CHIEF LEGAL OFFICER

    • Officer
    		 0 2023-02-17 2

    ROSIELLO ROBERT L.

    • Director
    		 40,000 2022-11-16 2

    NISSEN TORBEN STRAIGHT

    • Director
    		 40,000 2022-11-16 2

    SOCIETE DES PRODUITS NESTLE S.A.

    NESTLE SA

    • 10% Owner
    		 11,105,438 2022-10-13 1

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 29,251,545 2022-10-13 1

    FLAGSHIP PIONEERING INC.

    FPA GENERAL PARTNER LLC

    FPA, L.P.

    • 10% Owner
    		 3,048,780 2022-10-13 1

    SEKHRI PAUL J

    • Director
    		 40,000 2022-05-19 0

    EPSTEIN DAVID R

    • Director
    		 209,756 2022-05-19 0

    ROSENBLATT MICHAEL

    • Director
    		 40,000 2022-05-19 0

    BAIRD WILLIAM D III

    • Director
    		 20,000 2022-05-19 0

    SOHN CATHERINE A.

    • Director
    		 20,000 2022-05-19 0

    PISANO GARY P.

    • Director
    		 20,000 2022-05-19 0

    RONDINONE CRISTINA

    • Director
    		 20,000 2022-05-19 0

    HENDRIX MARTIN

    • Director
    		 40,000 2022-05-19 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 18,867,785 2022-03-16 1

    CRANE ROBERT CHIEF FINANCIAL OFFICER

    • Officer
    		 125,000 2022-03-16 0

    SCHECTER ALISON D. PRESIDENT - RESEARCH & DEV.

    • Officer
    		 56,000 2022-02-08 0

    DEAN VIRGINIA R SVP, CHIEF PEOPLE OFFICER

    • Officer
    		 71,400 2022-02-08 0

    BEHAR GREGORY

    • Director
    		 20,000 2021-05-20 0

    HOGE STEPHEN

    • Director
    		 20,000 2021-05-20 0

    ARADHYE SHREERAM

    • Director
    		 20,000 2021-05-20 0

    CHARDONNET LAURENT CHIEF FINANCIAL OFFICER

    • Officer
    		 6,266 2021-02-09 0

    CHAKRAVARTHY MANU SVP & CHIEF MEDICAL OFFICER

    • Officer
    		 0 2021-02-09 0

    BERRY DAVID A

    • Director
    		 No longer subject to file 2020-05-20 0

    NESTLE HEALTH SCIENCE US HOLDINGS, INC.

    SOCIETE DES PRODUITS NESTLE S.A.

    NESTLE SA

    NIMCO US, INC.

    NESTLE US HOLDCO, INC.

    • 10% Owner
    		 4,305,541 2020-05-18 0

    TRAMONTIN TONY SVP & CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2019-12-18 0

    MITCHENER STEPHEN SVP & CHIEF BUSINESS OFFICER

    • Officer
    		 0 2019-12-18 0

    KING-JONES HEIDY GENERAL COUNSEL, SVP LEGAL

    • Officer
    		 0 2019-12-18 0

    MALTBIE SHANE SEE REMARKS

    • Officer
    		 4,071 2019-08-21 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURELABS IV, LLC

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • 10% Owner
    		 7,665,995 2019-05-13 0

    VIEHBACHER CHRISTOPHER

    • Director
    		 0 2019-05-08 0

    LEGGETT THOMAS SVP FINANCE, CFO

    • Officer
    		 0 2019-05-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AXCELLA HEALTH INC AXLA 2023-06-06 22:15:03 UTC 0.8068 4.2632 30000
    AXCELLA HEALTH INC AXLA 2023-06-06 21:45:05 UTC 0.8068 4.2632 30000
    AXCELLA HEALTH INC AXLA 2023-06-06 21:15:04 UTC 0.8922 4.1778 30000
    AXCELLA HEALTH INC AXLA 2023-06-06 20:45:04 UTC 0.8922 4.1778 30000
    AXCELLA HEALTH INC AXLA 2023-06-06 20:15:04 UTC 0.8922 4.1778 30000
    AXCELLA HEALTH INC AXLA 2023-06-06 19:45:04 UTC 0.8922 4.1778 30000
    AXCELLA HEALTH INC AXLA 2023-06-06 19:15:03 UTC 0.8922 4.1778 30000
    AXCELLA HEALTH INC AXLA 2023-06-06 18:45:04 UTC 0.8922 4.1778 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 18:15:04 UTC 0.8922 4.1778 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 17:45:04 UTC 0.8922 4.1778 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 17:15:04 UTC 0.8922 4.1778 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 16:45:04 UTC 0.9619 4.0981 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 16:15:03 UTC 0.9619 4.0981 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 15:45:04 UTC 0.9619 4.0981 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 15:15:04 UTC 0.9619 4.0981 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 14:45:04 UTC 0.9206 4.1394 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 14:15:03 UTC 0.9206 4.1394 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 13:45:03 UTC 0.9206 4.1394 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 13:15:03 UTC 0.9206 4.1394 40000
    AXCELLA HEALTH INC AXLA 2023-06-06 12:45:05 UTC 0.9206 4.1394 45000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AXLA -3388.0 shares, $-1626.24 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments